X-154379496-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2
The NM_000117.3(EMD):c.12C>T(p.Tyr4=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000437 in 1,168,059 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 19 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000117.3 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EMD | NM_000117.3 | c.12C>T | p.Tyr4= | synonymous_variant | 1/6 | ENST00000369842.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EMD | ENST00000369842.9 | c.12C>T | p.Tyr4= | synonymous_variant | 1/6 | 1 | NM_000117.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000528 AC: 6AN: 113604Hom.: 0 Cov.: 26 AF XY: 0.0000559 AC XY: 2AN XY: 35748
GnomAD3 exomes AF: 0.0000173 AC: 2AN: 115306Hom.: 0 AF XY: 0.0000253 AC XY: 1AN XY: 39596
GnomAD4 exome AF: 0.0000417 AC: 44AN: 1054407Hom.: 0 Cov.: 31 AF XY: 0.0000464 AC XY: 16AN XY: 344827
GnomAD4 genome AF: 0.0000616 AC: 7AN: 113652Hom.: 0 Cov.: 26 AF XY: 0.0000838 AC XY: 3AN XY: 35806
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 19, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 03, 2020 | - - |
Cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Jun 02, 2021 | - - |
Emery-Dreifuss muscular dystrophy Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Feb 06, 2020 | - - |
X-linked Emery-Dreifuss muscular dystrophy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 05, 2024 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 02, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
EMD-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 17, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at